Vertically integrated cannabis company Sunniva (CSE: SNN)
(OTCQX: SNNVF) this morning announced the partnership between its wholly owned
subsidiary, Natural Health Services Ltd. (“NHS”), and HelloMD, a leading online
cannabis telehealth company, to extend telemedicine services to its patients
and provide more Canadian communities with convenient access to medical
cannabis advice. According to the update, HelloMD will provide its turnkey
white-label services to NHS, providing existing and future patients with online
health care practitioner consultation services. NHS currently operates a
network of seven medical cannabis clinics in four provinces, and the new option
will allow the company to extend its services to areas where there are not
existing clinics, reduce wait times and offer the convenience of evening and
weekend consultations. “Partnering with HelloMD enhances the NHS mission to
improve the way Canadians access safe, regulated medical cannabis and education
on how to use cannabis to improve health and quality of life,” NHS Medical
Director and Interim President Dr. Mark Kimmins stated in the news release. “By
utilizing the telehealth expertise of HelloMD, we will be able to increase our
patient base and serve the needs of more Canadians.”
To view the full press release, visit http://ibn.fm/Cwsj1
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically
integrated cannabis company operating in the world’s two largest cannabis
markets – Canada and California. Its ability to leverage large-scale,
purpose-built cGMP designed greenhouses, offering better quality assurance with
cannabis products free from pesticides, uniquely positions Sunniva as a leading
supplier of safe, high quality products at scale. Through its strategically
positioned cultivation and extraction facilities, Sunniva intends to launch a
suite of branded products in various product categories including flower,
pre-rolls, beverages, vape cartridges, and extracts while expanding upstream
opportunities including distribution and retail expansion. Sunniva’s management
and board of directors have a proven track record for creating significant
shareholder value both in the healthcare and biotech industries. For more
information, visit the company’s website at www.Sunniva.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
